S hort-term mortality after acute myocardial infarction (AMI) has diminished significantly over the past decade. 1, 2 Consequently, a greater proportion of clinical events affecting these patients include longer-term outcomes with cost and health status implications, such as rehospitalizations for unstable angina (UA) or unplanned coronary revascularization. Readmission rates have attracted major attention by payers and regulators in recent years, such that rehospitalization after AMI is now considered a marker of poor health care. 3 Although the economic implications of rehospitalizations are indisputable, 4 little is known about the association between these readmissions for UA and revascularization and patient-reported health status (symptoms, function, and quality of life [QOL]). Despite this lack of knowledge, such readmissions are often included as elements of composite end points in clinical trials to increase statistical efficiency. 5, 6 The problem of assuming that admissions for UA and revascularization are meaningful outcomes is particularly relevant, given findings of a recent study that asked clinical trialists and patients to rank individual components of composite end points in terms of their perceived importance. 7 Although there were some discrepancies between how trialists and patients ranked the different end points, both groups agreed that revascularizations and rehospitalizations were less important than the other end points of the composite (eg, stroke, myocardial infarction, and death). 7 As such, a better understanding of the Background-Rehospitalizations after acute myocardial infarction for unplanned coronary revascularization and unstable angina (UA) are common. However, despite the inclusion of these events in composite end points of many clinical trials, their association with health status has not been studied. Methods and Results-We included 3283 patients with acute myocardial infarction enrolled in a prospective, 24-center US study who had rehospitalizations independently classified by experienced cardiologists. Health status was assessed using Seattle Angina Questionnaire and EuroQol-5D Visual Analog Scale. In the propensity-matched cohorts, 1-year health status was compared between those who did and did not experience rehospitalization for UA or revascularization using a hierarchical linear model. Overall, mean age was 59 years, 33% were women, and 70% were white. Rehospitalization rates for UA and unplanned revascularization at 1 year were 4.3% and 4.7%. One-year Seattle Angina Questionnaire summary scores were worse in patients with rehospitalizations for UA (mean difference, −10.1; 95% confidence interval, −12.4 to −7.9) and unplanned revascularization (mean difference, −5.7; 95% confidence interval, −8.8 to −2.5) when compared with patients without such rehospitalizations. Similarly, EuroQol-5D Visual Analog Scale scores were worse among patients with such readmissions. Individual Seattle Angina Questionnaire domains indicated worse 1-year angina and quality of life outcomes among patients rehospitalized for UA or unplanned revascularization. Conclusions-Within the first year after acute myocardial infarction, rehospitalizations for UA and unplanned revascularization are associated with worse health status. These findings highlight the impact of such events from a patient's perspective, beyond their economic impact and support the use of UA and unplanned revascularization as elements of composite end points. (Circ Cardiovasc Qual Outcomes. 2016;9:777-784.
clinical importance of these rehospitalizations could support their inclusion in composite end points for clinical reasons, beyond their obvious economic impact. 7 To our knowledge, no studies have evaluated the relationship between rehospitalization and health-related QOL.
Given these gaps in knowledge, the objective of this study was to examine the association between rehospitalizations for recurrent ischemic coronary events (including UA and unplanned coronary revascularization) and prospectively collected 1-year health status outcomes in a large multicenter registry of patients with AMI. More specifically, we examined the association between rehospitalizations for UA or unplanned revascularization after AMI discharge with the validated disease-specific Seattle Angina Questionnaire (SAQ) and the generic EuroQol-5D Visual Analogue Scale (EQ-5D VAS) in propensity-matched cohorts. We hypothesized that patients with rehospitalizations for UA and unplanned coronary revascularizations will have worse 1-year health status when compared with patients who did not experience these readmissions.Methods
Data Source
The analytic cohort for this study was derived from the Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction patients' Health Status (TRIUMPH) registry. TRIUMPH is a prospective, multicenter, observational registry that enrolled 4340 patients with AMI from 24 US medical centers between April 11, 2005 , and December 31, 2008. The study design has been previously described in detail. 8 In brief, eligible patients were those aged ≥18 years with a diagnosis of AMI within 24 hours of admission. AMI was defined as an elevated troponin level supported by either electrocardiographic criteria (ST changes in ≥2 consecutive leads) or other clinical features of ischemia (prolonged ischemic signs/symptoms). Participants were required to present at the enrolling site or be transferred within 24 hours of presentation so that primary clinical decision making occurred at the enrolling center. Trained abstractors using standard reporting forms manually abstracted hospital records, medications, and treatments. Clinical covariates and treatment characteristics were prospectively defined, wherever possible, by using the American College of Cardiology/American Heart Association clinical standards for acute coronary syndrome definitions. 9 In addition, each consenting patient underwent a standardized in-person interview by trained research staff to document demographic, psychosocial, and clinical data at baseline. Follow-up telephone interviews were attempted on all survivors at 1, 6, and 12 months after their index AMI. During these follow-up interviews, detailed assessments of current medications, lifestyle, health status, and secondary risk factor management practices were collected. Patients were also asked at the time of their index AMI admission to consent to medical record abstractions of hospitalizations over the next year. All patients signed an informed consent approved by participating institution, and institutional review board approval was obtained at each participating center.
Study Cohort
We included all patients enrolled in TRIUMPH who survived for at least 1 month after the index AMI hospitalization and had follow-up data with rehospitalization data available for adjudication ( Figure) . All staged or elective percutaneous coronary interventions (PCI)/ coronary artery bypass grafts (CABG) that were planned at the time of the initial AMI were excluded. In addition, any PCI or CABG performed within the first month after the index AMI were excluded because health status could be influenced by continued angina caused by incomplete revascularization, unless these events occurred in the setting of an acute coronary syndrome.
Exposure Variables
The exposure variables of interest in our models were rehospitalizations for UA and unplanned coronary revascularization within 1 year after index AMI. These were assessed during the follow-up interviews at 1, 6, and 12 months after initial AMI hospitalization. During these follow-up interviews, all patients were asked to report interval events (eg, procedures, diagnostic tests, hospitalizations, and outpatient visits) since their last study contact. If a patient reported being hospitalized since the previous interview, records of that hospitalization were obtained to classify cardiovascular events, including UA and coronary revascularization procedures. Chart abstractions were sent to 2 cardiologists who independently classified the reason for hospitalization. If there was disagreement between the 2 cardiologists, the record was adjudicated by a third senior cardiologist and, if disagreement persisted, up to 5 cardiologists independently reviewed the charts until consensus was obtained.
UA was defined, per guidelines, as a hospitalization caused by symptoms suggestive of ischemia that was of new onset, was increasing in severity (ie, more frequent, longer in duration, or lower in threshold), or occurred at rest. 10 An unplanned revascularization was defined as a revascularization procedure that was not planned at the time of the index AMI admission and was not performed in the setting of a recurrent AMI (to avoid examining the clinical impact of recurrent AMIs that has already been described in the existing literature). 11 All PCI and elective CABG surgeries performed within 1 month of the index AMI were excluded to avoid accounting for staged revascularization procedures that were planned at the time of index AMI hospitalization as symptoms from incomplete revascularization could impact health status, unless these events occurred in the setting of an acute coronary syndrome. Unplanned revascularizations and UA were treated as nonmutually exclusive exposure variables. In our definition of unplanned repeat revascularizations, we excluded procedures performed for subsequent AMI.
Outcome Variables
The outcomes of interest in our models were disease specific and generic health status outcomes after the index AMI. In the TRIUMPH registry, disease-specific health status was assessed at baseline, 1, 6, and 12 months after the index AMI using the SAQ. The SAQ is a validated 19-item questionnaire that measures 5 domains of health status related to coronary artery disease: angina frequency (SAQ-AF), physical limitation, SAQ-QOL, angina stability, and treatment satisfaction. 12, 13 Scores for each domain range from 0 to 100, with higher scores indicating better health status. Previous validation studies have
WHAT IS KNOWN
• Rehospitalizations for unstable angina and unplanned coronary revascularization are commonly used in composite end points for cardiovascular clinical trials to improve statistical efficacy. 
WHAT THE STUDY ADDS
• In the year after an acute myocardial infarction, rehospitalizations for unstable angina and unplanned coronary correlated with clinically significant decrements in disease-specific and global health status measures. • These observations suggest that rehospitalizations have a sustained meaningful impact on patients and their use in composite end points can reflect worse health status.
shown that components of the SAQ score correlate well with commonly used clinical measures. 13 The SAQ-physical limitation score correlates with exercise treadmill time with lower scores suggesting shorter total exercise duration. The SAQ-AF score correlates with nitroglycerine prescription refills with lower scores suggesting more nitroglycerine use. The SAQ-QOL correlates with the general health scale of the Short Form-36, which is a measure of personal evaluation of health, health outlook, and resistance to illness. Lower SAQ-QOL scores suggest worse QOL. Recently, a summary score that incorporates data from the physical limitation, AF, and QOL domains has been introduced to summarize patients' disease-specific health status. 14 Accordingly, for this study, we focused on these 3 SAQ and the SAQ summary score. Although an 8-to 10-point difference on the SAQ had originally been described as a threshold for clinical importance, 13 differences of 4 points have been reported as clinically important within the context of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial. 15 We assessed generic health status using the EQ-5D VAS that was measured in the TRIUMPH registry at baseline, 1, 6, and 12 months postindex AMI. The EQ-5D VAS captures patients' self-rating of their health on a 20-cm vertical visual analog scale with the end points being best imaginable health state (corresponding score=100) and worst imaginable health state (corresponding score=0). 16 The minimum clinically important difference for the EQ-5D VAS ranges from 7 to 12 for patients with various clinical conditions. 17 However, the minimum clinically important difference in EQ-5D VAS scores for patients with coronary artery disease has not been formally established.
We measured the mean difference between health status at 1 year between patients with and without UA rehospitalization and similarly and between patients with and without unplanned revascularization after index AMI. This was primarily because health status measures may show a transient decrement after AMI hospitalizations. Hence, baseline health status measured in our population at the time of index AMI admission may be transiently lower. Therefore, we did not measure change in health status from baseline but modeled 1-year health status outcomes to more accurately assess the impact of rehospitalizations.
Propensity Matching
To evaluate the association between readmissions for UA and unplanned coronary revascularization after AMI and 1-year health status outcomes, we sought to identify a group of patients without these events that was similar to those that experienced them. This was accomplished through the creation of propensity scores with UA and unplanned revascularization as the outcomes. We included a wide range of variables based on previous literature 18 and clinical rationale to generate propensity-matched cohorts for UA versus no UA rehospitalizations and for unplanned coronary revascularization rehospitalizations versus no repeat revascularization procedures.
Demographic covariates included age, sex, race, educational, marital, insurance, and work status. Clinical covariates included body mass index, previous AMI (before the AMI at index hospitalization), previous CABG, previous stroke/transient ischemic attack, previous angina, cancer, diabetes mellitus, hypertension, hypercholesterolemia, peripheral vascular disease, chronic kidney disease, dialysis, chronic heart failure, chronic lung disease, left ventricular systolic dysfunction, ST-segment-elevation AMI, family history of coronary artery disease, depression, and baseline health status (as measured by SAQ-AF and QOL scores, Short Form-12 version 2 physical and mental component summaries 19 ). We also included clinical characteristics at index AMI admission such as initial systolic blood pressure, heart rate, Global Registry of Acute Coronary Event risk score 20 and highest serum troponin level. In addition, treatment characteristics at index AMI admission included aspirin, β-blockers, statins, angiotensin antagonists, thienopyridines, and insulin on arrival and at discharge, and in-hospital PCI and CABG were also included in generating propensity-matched cohorts.
Statistical Analysis
To account for differences in characteristics of patients with and without UA rehospitalization, propensity scores were derived to assess the probability of undergoing an UA rehospitalization. This was done by constructing nonparsimonious, multivariable logistic regression models with UA rehospitalization as the dependent variable, and all the aforementioned covariates as predictors. Site of initial hospitalization entered the propensity model as a fixed-effect covariate to account for clustering by site. Any missing data for baseline variables were imputed by sequential regression imputation incorporating all baseline variables. We then optimally matched patients with UA rehospitalization with those without rehospitalization using greedy matching on the logit of the propensity score in which 1 case could be matched to ≥1 controls. The caliper width was chosen as 0.2× the pooled SD of the logit propensity scores for the groups. Balance of baseline characteristics between groups before and after matching was examined using absolute standardized differences with a standardized difference of <10% considered to indicate good balance between the groups. 21 We used the same approach to develop another propensity-matched cohorts for those with and without rehospitalizations for unplanned coronary revascularization.
Next, we used the matched cohorts to fit a hierarchical linear model for 1-year health status outcomes over the year after AMI (SAQ anginal frequency, physical limitation, QOL, and summary score domains and EQ-5D VAS). To take into account the clustering of matched sets, we centered the independent variables over the means within each matched set, and the matched sets were entered into the model as a random effect. Two models were fitted: unadjusted and adjusted for baseline SAQ summary, SAQ component scores, and EQ-5D VAS scores. The latter model was constructed to account 
Results

Patient Population
Between April 11, 2005 , and December 31, 2008, a total of 4340 patients were enrolled in the TRIUMPH registry. We excluded patients who died within the first month and never had the opportunity for follow-up (n=71), patients lost to follow-up (n=637), and patients for whom data on rehospitalization after index AMI were unavailable for adjudication due to patients' refusal to share their hospital records (n=77) or hospitals refusing to accept the patients' medical record release forms (n=272). The final analytic cohort consisted of 3283 (75.6%; Figure) patients who had either no rehospitalizations or all reported rehospitalization data available for adjudication. The propensity-matched cohort for UA rehospitalization included 2433 (56.1%) patients, and the propensity-matched cohort for unplanned coronary revascularization rehospitalization included 2410 (55.5%) patients. Overall, the mean age of patients included in our cohort was 59 years, 33% were women, and 70% were white. As expected, the comorbidity burden was high with 66% patients having hypertension, 29% with diabetes mellitus, 20% with previous MI, 19% with previous PCI, and 11% with previous CABG. Table 1 shows baseline characteristics of matched patients with and without UA and unplanned revascularization rehospitalizations. There were no statistically significant differences between the matched groups as suggested by the small effect sizes for any differences.
UA Rehospitalization and Health Status
In the first year after index AMI hospitalization, there were 140 (4.3%) rehospitalizations because of UA with a median time-to-event of 4.1 months (interquartile range, 1.2-7.3 months). The mean follow-up duration for the UA cohort was 10.8±3.1 months. Table 2 shows unadjusted SAQ summary and EQ-5D VAS scores at baseline and 1 year in the propensity-matched cohort. Baseline SAQ summary scores between those with and without UA rehospitalization were similar (76.4 versus 79.3; P=0.058). In contrast, follow-up diseasespecific SAQ summary score over the 12 months after index AMI admission was lower (indicating worse health status) in patients with UA rehospitalization than in those without. The mean difference in SAQ scores was −10.5 points (95% confidence interval [CI], −13.0 to −8.1; Table 3 ). This persisted after adjusting for baseline health status (mean change >12 months, −10.1 points; 95% CI, −12.4 to −7.9). Findings were similar for individual SAQ domains over the 12-month follow-up period, both before and after adjustment for other clinical characteristics indicating more angina, worse physical function, and poorer QOL ( Table 3) .
Generic health status scores measured by EQ-5D VAS were similar at baseline in the propensity-matched cohorts between those with UA rehospitalizations and those without (63.3 versus 65.9; P=0. 16) . During the year after index AMI admission, patients with UA rehospitalization had lower EQ-5D VAS scores (indicating worse health status), both before and after accounting for baseline scores ( Table 3) .
As a sensitivity analysis, we excluded all patients with rehospitalizations for AMI or staged PCI. Our results remained unchanged with patients with UA rehospitalizations having worse health status with lower SAQ summary scores and EQ-5D VAS scores when compared with patients without such rehospitalizations ( Table III in 
Unplanned Revascularization and Health Status
In the first year after index AMI, there were 113 (4.7%) rehospitalizations for unplanned coronary revascularizations with a median time-to-event of 3.6 months (interquartile range, 1.5-7.4 months). This included 102 rehospitalizations for PCIs, 10 for CABG, and 1 for both CABG and PCI. The mean followup duration was 10.9±3.0 months. Table 4 shows the association between unplanned revascularization and patient's 1-year health status after index AMI. In the propensity-matched cohort, baseline SAQ summary scores were similar in patients with and without unplanned revascularization rehospitalization (77.5 versus 79.1; P=0.32; Table 2 ). However, SAQ summary score >12 months after index AMI was lower (indicating worse health status; Table 2 ) in patients with unplanned revascularization when compared with those without (mean change, −5.7 points; 95% CI, −9.0 to −2.4; Table 4 ). This finding persisted after adjusting for baseline health status (mean change >12 months, −5.7; 95% CI, −8.8 to −2.5). SAQ-AF and SAQ-QOL scores were also significantly lower among those with unplanned revascularization than among those without unplanned revascularization (Table 4) .
Generic health status scores measured by EQ-5D VAS were similar at baseline in the propensity-matched cohorts between those with and without unplanned revascularization (63.0 versus 65.8; P=0.18). However, at follow-up, patients with unplanned revascularization had worse EQ-5D VAS scores >12 months (mean change, −5.3; 95% CI, −9.6 to −0.9; Table 4 ). As with the SAQ scores, generic health status also worsened among patients with unplanned revascularization after adjustment for baseline scores (mean change, −4.4; 95% CI, −8.4 to −0.3).
After excluding all patients with rehospitalizations for AMI and staged PCI, patients with rehospitalizations for unplanned coronary revascularizations still had worse health status with lower SAQ summary and EQ-5D VAS scores ( Table III in 
Discussion
Although UA and unplanned revascularization are often considered major adverse coronary events, their association with patients' health status has never been previously described. In a large, prospective registry of patients with AMI, we observed that rehospitalizations after an AMI for UA or unplanned coronary revascularizations are associated with statistically and clinically significant decrements in both generic and disease-specific 1-year health status outcomes as measured by established, well-validated health status instruments. These findings persisted after applying propensity matching for a large number of patient and treatment characteristics that could confound this association and after adjusting for health status at baseline. Our observations suggest that patient health status is clinically important as a marker of population-level cardiovascular health.
Annually >715 000 Americans are hospitalized with an AMI. 22 With progressive improvements in acute care over the past several decades, the vast majority of patients with AMI survive their index AMI hospitalization. Accordingly, there is increased interest in other clinical outcomes and quality metrics, including reducing rehospitalizations that consume significant healthcare resources. In fact, early readmission has recently gained traction as a quality of care measure. 3 Although the economic implications of rehospitalizations are self-evident, 4 previous studies have raised concerns about the use of rehospitalizations as an outcome within the composite end point of clinical trials. Part of this concern stems from the knowledge that these events are, in part, determined by the actions of clinicians and patients, rather than by the disease process alone. 23 For example, in a recent review of cardiovascular clinical trials using composite end points, the authors categorized rehospitalizations and revascularizations as least important from a patient's perspective. 7 However, our study provides new insights into the interaction between patients' health status and such rehospitalizations, as we found a consistent association between rehospitalizations and poorer patient health status, thus establishing that these events are markers of worse patient-centered health outcomes. 7 These observations suggest that rehospitalizations for UA and unplanned coronary revascularization have a sustained and clinically meaningful impact on patients beyond the transient inconvenience they cause. Accordingly, when health status outcomes are not directly measured in a clinical trial, the occurrence of an unplanned revascularization and UA can reflect worse health status and justify their inclusion in composite outcomes. That said, directly measuring the patients' perspectives of their health would be a more direct, and preferred, measure of outcomes.
The results of our study should be interpreted in the context of several potential limitations. First, we only included patients for whom all rehospitalizations were available for adjudication, which introduces a selection bias into our study by excluding those patients with important clinical events. However, this analysis was designed to address the clinical importance of UA and unplanned or early clinically driven repeat revascularization among those who survived their AMI (death is always considered a relevant end point in clinical trials or quality assessment efforts). Moreover, the use of adjudicated rehospitalizations for identifying such events is a major *Mean difference in SAQ and EuroQol scores at 1 year between patients with and without unplanned coronary revascularizations strength in our study as compared with using administrative codes. Second, we relied on self-reported rehospitalizations, which were subsequently validated by review of hospitalization records. This could potentially lead to under-reporting of rehospitalizations because of recall bias. Nonetheless, this would bias our results toward the null. In addition, as with all other observational studies, we cannot prove a causal association or directionality in the association between rehospitalizations and patient health status. Residual confounding, for example, from other reasons for admissions, as opposed to our conclusion that these events are markers of worse health status, cannot be definitively established. To minimize the risk of residual confounding, we accounted for a large number of covariates known to modify this association and generated propensity-matched cohorts in an attempt to reduce this source of error.
In conclusion, in AMI survivors who experienced subsequent readmissions for UA, worse 1-year patient health status outcomes were noted when compared with patients who did not experience such readmissions; we found a similar association between rehospitalizations for unplanned revascularizations and 1-year patient health status. These findings highlight the interaction between patient health status and repeat rehospitalizations for UA and unplanned coronary revascularizations beyond their economic impact to society. Although our findings may justify the use of rehospitalizations as an end point in clinical trials, they also suggest a need for future research to better define whether close monitoring of patients' health status might identify those at risk for readmission, who therefore could be targeted for more aggressive treatment strategies to prevent rehospitalizations while also preserving or improving health status.
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